Richard M. Ransohoff, M.D., Richard is Director of the Neuroinflammation Research Center in the Dept. of Neurosciences of the Lerner Research Institute, Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine, and Staff Neurologist in the Mellen Center for MS Treatment and Research, both at the Cleveland Clinic Foundation (CCF), Cleveland, OH. Dr. Ransohoff graduated with honors from Bard College, Annandale, NY with a B.A. in Literature, and received the M.D. degree with honors from Case School of Medicine, Cleveland, OH. He completed residencies in Internal Medicine (Mt. Sinai Medical Center, Cleveland, OH; Board Certified 1981) and Neurology (CCF; Board Certified 1985). From 1984 until 1989, Dr. Ransohoff was a post-doctoral fellow in the laboratory of Dr. Timothy Nilsen, Dept. of Molecular Biology and Microbiology, Case School of Medicine. Dr. Ransohoff served as regular member on study sections of the NIH and NMSS (as Chair). He has served on the Editorial Boards of The Journal of Immunology, (2002-2005 as Section Editor) Trends in Immunology, the Journal of Neuroimmunology; Nature Reviews Immunology, and Neurology (Associate Editor). He is a member of the Steering Committee for the NIH Therapeutic Development Program in Spinal Muscular Atrophy; the International Advisory Boards for the 7th (2004) and 8th (2006) Congresses on Neuroimmunology; and the Scientific Advisory Board for Chemocentryx, Mountain View, CA. He serves on External Advisory Boards for CHARTER (CNS HIV Anti-Retroviral Therapy Effects Research; MH22005); a Program Project on Alexander's Disease (NS 42803); the MS Lesion Project (NMSS RG 3185); the University of Nebraska's Center for Neurovirology & Neurodegenerative Disorders (NS43985) and was the External Advisor for the European Union's Project on 'Mechanisms of Brain Inflammation" (QLG3-00612). He is a member of the National MS Society's Medical Advisory Board. He is the Co-director of the Marine Biological Laboratory's special topics course on "Pathogenesis of neuroimmunological disease" held biennially at Wood's Hole, MA. He is a member of the External Advisory Board for Meharry Medical College's Special Neuroscience Rsearch Program (SNRP). For the past decade, Dr. Ransohoff's research has focused on the functions of chemokines and chemokine receptors in development and pathology of the nervous system. He also has a longstanding and continuing interest in the mechanisms of action of interferon-beta. Dr. Ransohoff has received research support from the NIH and the NMSS. He has published more than 150 scientific reports, more than 50 reviews and book chapters, and three edited books. Dr. Ransohoff is a member of the American Academy of Neurology, the American Neurological Association, the American Association for the Advancement of Science and the American Association of Immunologists.